These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16496211)

  • 1. Factors affecting hospital staff judgments about sickle cell disease pain.
    Elander J; Marczewska M; Amos R; Thomas A; Tangayi S
    J Behav Med; 2006 Apr; 29(2):203-14. PubMed ID: 16496211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence.
    Elander J; Lusher J; Bevan D; Telfer P; Burton B
    J Pain Symptom Manage; 2004 Feb; 27(2):156-69. PubMed ID: 15157040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic addiction and pseudoaddiction in painful chronic illness.
    Lusher J; Elander J; Bevan D; Telfer P; Burton B
    Clin J Pain; 2006; 22(3):316-24. PubMed ID: 16514333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain management and symptoms of substance dependence among patients with sickle cell disease.
    Elander J; Lusher J; Bevan D; Telfer P
    Soc Sci Med; 2003 Nov; 57(9):1683-96. PubMed ID: 12948577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHEDRE trial protocol - observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population.
    Gérardin M; Couec ML; Grall-Bronnec M; Feuillet F; Wainstein L; Rousselet M; Pinot ML; Perrouin F; Bonnot O; Drouineau MH; Jolliet P; Victorri-Vigneau C
    BMC Psychiatry; 2015 Nov; 15():281. PubMed ID: 26573686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' attitude and practices in sickle cell disease pain management.
    Labbé E; Herbert D; Haynes J
    J Palliat Care; 2005; 21(4):246-51. PubMed ID: 16483093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency department management of acute pain episodes in sickle cell disease.
    Tanabe P; Myers R; Zosel A; Brice J; Ansari AH; Evans J; Martinovich Z; Todd KH; Paice JA
    Acad Emerg Med; 2007 May; 14(5):419-25. PubMed ID: 17389246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on sickle cell disease: incidence of addiction and choice of opioid in pain management.
    Morrison RA
    Pediatr Nurs; 1991; 17(5):503. PubMed ID: 1923659
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers to effective pain management in sickle cell disease.
    Wright K; Adeosum O
    Br J Nurs; 2009 Feb 12-25; 18(3):158-61. PubMed ID: 19223799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health professional perceptions of opioid dependence among patients with pain.
    Waldrop RD; Mandry C
    Am J Emerg Med; 1995 Sep; 13(5):529-31. PubMed ID: 7662056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurses' attitudes and practices in sickle cell pain management.
    Pack-Mabien A; Labbe E; Herbert D; Haynes J
    Appl Nurs Res; 2001 Nov; 14(4):187-92. PubMed ID: 11699021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing patients' concerns about pain management and addiction risks.
    Goebel JR; Sherbourne CD; Asch SM; Meredith L; Cohen AB; Hagenmaier E; Lanto AB; Simon B; Rubenstein LV; Shugarman LR; Lorenz KA
    Pain Manag Nurs; 2010 Jun; 11(2):92-8. PubMed ID: 20510839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of analgesic use in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease.
    Inoue S; Khan I; Mushtaq R; Sanikommu SR; Mbeumo C; LaChance J; Roebuck M
    Ann Hematol; 2016 Jan; 95(2):221-5. PubMed ID: 26611852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analgesic abuse and psychiatric comorbidity in headache patients].
    Radat F; Irachabal S; Swendsen J; Henry P
    Encephale; 2002; 28(5 Pt 1):466-71. PubMed ID: 12386550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of contextual variables on judgments about patients and their pain.
    Twigg OC; Byrne DG
    Pain Med; 2015 Jan; 16(1):88-98. PubMed ID: 25280115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on pain management in sickle cell disease.
    Ballas SK
    Hemoglobin; 2011; 35(5-6):520-9. PubMed ID: 21910604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.